A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS)

Drug Safety ◽  
2020 ◽  
Vol 43 (6) ◽  
pp. 607-609
Author(s):  
Kate E. Rees ◽  
Te-yuan Chyou ◽  
Prasad S. Nishtala
Drug Safety ◽  
2020 ◽  
Vol 43 (5) ◽  
pp. 457-465 ◽  
Author(s):  
Kathryn Marwitz ◽  
S. Christopher Jones ◽  
Cindy M. Kortepeter ◽  
Gerald J. Dal Pan ◽  
Monica A. Muñoz

Drug Safety ◽  
2012 ◽  
Vol 35 (6) ◽  
pp. 507-518 ◽  
Author(s):  
Behrooz K. Shamloo ◽  
Pankdeep Chhabra ◽  
Andrew N. Freedman ◽  
Arnold Potosky ◽  
Jennifer Malin ◽  
...  

Drug Safety ◽  
2010 ◽  
Vol 33 (2) ◽  
pp. 139-146 ◽  
Author(s):  
Steven Bailey ◽  
Ajay Singh ◽  
Robert Azadian ◽  
Peter Huber ◽  
Michael Blum

JGH Open ◽  
2021 ◽  
Author(s):  
Mohamed Kadry Taher ◽  
Abdallah Alami ◽  
Christopher A. Gravel ◽  
Derek Tsui ◽  
Lise M. Bjerre ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document